• Industry-sponsored clinical studies

In 2010, 50 new clinical studies were contracted and the cumulative number of contracted clinical studies reached 569. Ongoing studies remained at a high level of 206 by the end of the year.

.

•Distribution in study area and study phase

During the year, oncology and cardiovasculology continued to be the top areas in terms of study number. The two areas accounted for 46% and 16%, respectively, among the 50 contracted clinical studies. Phase II and phase III studies together accounted for 76% of all newly contracted studies.